Yeah, I was in a good mood last night, and it cost me a couple of hours.
Hey..... looky at GZSP and a few other issues today.... I seem to be in a good mood today, too. Anyone else?
- vbg -
I sold most of my VPHM yesterday morning at about 16. I got 22 for a smaller chunk, however, and I held 10% of the position. This is the second time I've owned it. I got it 12/28 at 12 1/8 and didn't hold it long.
Severe colds are debilitating. The costs to world economies are enormous. Medicine will need to keep up with a changing world, driven by issues which include productivity, population densities, and travel. If you believe that it will never be acceptable to apply a standardized chemical force on a virus, I can understand why you feel so strongly about the "hype". I didn't watch the CEO on TV or pay any attention to anything beyond the release..... did the company embarrass itself?
At a recent Informed Investors forum, I asked the V.P. Business Development about the spectrum of viral replicates that were "recognized" by plec. Answer was interesting. RSV, 1 nM potent, bioavail if inhaled, tox > 20 mg/kg. HCV target for clinic was late '99, oral bioavail, tox > 100 mg/kg.
Stated plan was to contract manufacture, hire specialty sales force, and co-promote in large markets.
|
